Sort   by:  
 Page size 
ProteomicsSMAD nucleocytoplasmic shuttling relies on nucleoporin RanBP2 and VIM-AS1 long non-coding RNA during TGF-β signaling
Activation of the transforming growth factor β (TGF-β) signaling leads to established hallmarks of cancer such as the epithelial-to-mesenchymal transition (EMT), initiating cancer dissemination and increasing chemoresistance. TGF-β signal by binding to its type I and II receptors, leading to paralle...
ORGANISM(S): Homo sapiens (Human) 
2026-01-26 | PXD057186 | Pride
Cancer  epithelial-to-mesenchymal transition  long non-coding rna  nucleoporin  smad  transforming growth factor β  vim-as1 
GenomicsEffect of overexpression of VIM-AS1 on gene expression in LNCaP cells
Effect of overexpression of VIM-AS1 on gene expression in LNCaP cells
PRJNA909294 | ENA
TranscriptomicsEffect of overexpression of VIM-AS1 on gene expression in LNCaP cells
Purpose: To detect the diffirential expressed genes in LNCaP cells transfected with VIM-AS1 overexression vetor and control pcDNA3.1 vector Method: Transcriptome sequencing was sued to detect the diffirential expressed genes in LNCaP cells transfected with VIM-AS1 overexression vetor and control pcD...
ORGANISM(S): Homo sapiens 
2022-12-08 | GSE220250 | GEO
TranscriptomicsSMAD nucleocytoplasmic shuttling relies on nucleoporin RanBP2 and VIM-AS1 long non-coding RNA during TGF-β signaling
Activation of the transforming growth factor β (TGF-β) signaling leads to established hallmarks of cancer such as the epithelial-to-mesenchymal transition (EMT), initiating cancer dissemination and increasing chemoresistance. TGF-β signal by binding to its type I and II receptors, leading to paralle...
ORGANISM(S): Homo sapiens 
2025-12-22 | GSE281521 | GEO
GenomicsSMAD nucleocytoplasmic shuttling relies on nucleoporin RanBP2 and VIM-AS1 long non-coding RNA during TGF-β signaling
SMAD nucleocytoplasmic shuttling relies on nucleoporin RanBP2 and VIM-AS1 long non-coding RNA during TGF-β signaling
PRJNA1184177 | ENA
TranscriptomicsLong Noncoding VIM-AS1: Biomarker of Breast Fibrosis Susceptibility After Radiation Therapy and Promoter of Transforming Growth Factor Beta1–Driven Fibrosis
Purpose: Fibrosis is a common late complication of radiation therapy. Molecular dysregulations leading to fibrosis have been characterized for the coding part of the genome, notably those involving the TGFB1 gene network. However, because a large part of the human genome encodes RNA transcripts that...
ORGANISM(S): Homo sapiens 
2024-10-24 | GSE256420 | GEO
UnknownVIM‑AS1 promotes proliferation and drives enzalutamide resistance in prostate cancer via IGF2BP2‑mediated HMGCS1 mRNA stabilization.
Not available
S-EPMC9911078 | biostudies-literature
UnknownLncRNAs LY86-AS1 and VIM-AS1 Distinguish Plasma Cell Leukemia Patients from Multiple Myeloma Patients.
Not available
S-EPMC8615960 | biostudies-literature
GenomicsLong Noncoding VIM-AS1: Biomarker of Breast Fibrosis Susceptibility After Radiation Therapy and Promoter of Transforming Growth Factor Beta1–Driven Fibrosis
Long Noncoding VIM-AS1: Biomarker of Breast Fibrosis Susceptibility After Radiation Therapy and Promoter of Transforming Growth Factor Beta1–Driven Fibrosis
PRJNA1079387 | ENA
UnknownLncRNA VIM-AS1 is a potential prognostic biomarker and effects on tumor cellular behaviors in breast cancer via impairing miR-29a-3p.
Not available
S-EPMC12495003 | biostudies-literature
Sort   by:  
 Page size